74696 Federal Register / Vol. 76, No. 231 / Thursday, December 1, 2011 / Rules and Regulations 

* * * * * 

Alan D. Bersin, 

Commissioner, U.S. Customs and Border 

Protection. 

Approved: November 28, 2011. 

Timothy E. Skud, 

Deputy Assistant Secretary of the Treasury. 

[FR Doc. 2011–30905 Filed 11–30–11; 8:45 am] 

BILLING CODE 9111–14–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

21 CFR Part 1314 

[Docket No. DEA–328] 

RIN 1117–AB25 

Implementation of the 

Methamphetamine Production 

Prevention Act of 2008 

AGENCY: Drug Enforcement 

Administration (DEA), Justice. 

ACTION: Final rule. 

SUMMARY: In October 2008, the President 

signed the Methamphetamine 

Production Prevention Act of 2008 

(MPPA), which clarifies the information 

entry and signature requirements for 

electronic logbook systems permitted for 

the retail sale of scheduled listed 

chemical products. On March 23, 2010, 

DEA published a Notice of Proposed 

Rulemaking to implement the 

provisions of the MPPA and make its 

regulations consistent with the new 

requirements. This action finalizes 

without change the Notice of Proposed 

Rulemaking published on March 23, 

2010. The Final Rule will make it easier 

for regulated sellers to maintain 

electronic logbooks by allowing greater 

flexibility as to how information may be 

captured. 

DATES: Effective Date: January 3, 2012. 

FOR FURTHER INFORMATION CONTACT: 

Rhea D. Moore, Office of Diversion 

Control, Drug Enforcement 

Administration, 8701 Morrissette Drive, 

Springfield, Virginia 22152; Telephone 

(202) 307–7165. 

SUPPLEMENTARY INFORMATION: 

DEA’s Legal Authority 

DEA implements the Comprehensive 

Drug Abuse Prevention and Control Act 

of 1970, often referred to as the 

Controlled Substances Act (CSA) and 

the Controlled Substances Import and 

Export Act (CSIEA) (21 U.S.C. 801–971), 

as amended. DEA publishes the 

implementing regulations for these 

statutes in Title 21 of the Code of 

Federal Regulations (CFR), Parts 1300 to 

1321. These regulations are designed to 

ensure that there is a sufficient supply 

of controlled substances for legitimate 

medical, scientific, research, and 

industrial purposes and to deter the 

diversion of controlled substances to 

illegal purposes. 

The CSA mandates that DEA establish 

a closed system of control for 

manufacturing, distributing, and 

dispensing controlled substances. Any 

person who manufactures, distributes, 

dispenses, imports, exports, or conducts 

research or chemical analysis with 

controlled substances must register with 

DEA (unless exempt) and comply with 

the applicable requirements for the 

activity. The CSA as amended also 

requires DEA to regulate the 

manufacture and distribution of 

chemicals that may be used to 

manufacture controlled substances 

illegally. Listed chemicals that are 

classified as List I chemicals are 

important to the manufacture of 

controlled substances. Those classified 

as List II chemicals may be used to 

manufacture controlled substances. 

Background 

On March 9, 2006, the President 

signed the Combat Methamphetamine 

Epidemic Act of 2005 (CMEA), which is 

Title VII of the USA PATRIOT 

Improvement and Reauthorization Act 

of 2005 (Pub. L. 109–177). CMEA 

amended the CSA to regulate the sale of 

products that contain ephedrine, 

pseudoephedrine, and 

phenylpropanolamine, their salts, 

optical isomers, and salts of optical 

isomers, that may be marketed or 

distributed lawfully in the United States 

under the Federal Food, Drug, and 

Cosmetic Act as nonprescription drugs. 

CMEA defines these products as 

‘‘scheduled listed chemical products’’ 

(21 U.S.C. 802(45)). Ephedrine, 

pseudoephedrine, and 

phenylpropanolamine are List I 

chemicals because they are used in, and 

important to, the illegal manufacture of 

methamphetamine and amphetamine, 

both Schedule II controlled substances. 

The Methamphetamine Production 

Prevention Act of 2008 (MPPA) (Pub. L. 

110–415) was enacted in 2008 to clarify 

the information entry and signature 

requirements for electronic logbook 

systems permitted for the retail sale of 

scheduled listed chemical products. On 

March 23, 2010, DEA published a 

Notice of Proposed Rulemaking to 

implement the provisions of the MPPA 

and make its regulations consistent with 

the new requirements. 75 FR 13702. 

This finalizes that proposed rulemaking. 

Requirements for Retail Sales of 

Scheduled Listed Chemical Products 

CMEA defines nonprescription drug 

products marketed or distributed 

lawfully in the United States under the 

Federal Food, Drug, and Cosmetic Act 

containing ephedrine, pseudoephedrine, 

or phenylpropanolamine as ‘‘scheduled 

listed chemical products’’ (21 U.S.C. 

802(45)). Direct, in-person sales to a 

customer, whether by a regulated seller 

(e.g., grocery store, general merchandise 

store, drug store) (21 U.S.C. 802(46), 

(49)) or a mobile retail vendor (e.g., 

kiosk, flea market), (21 U.S.C. 802(47)) 

are subject to requirements for training 

of employees who either are responsible 

for delivering scheduled listed chemical 

products into the custody of purchasers 

or who deal directly with purchasers by 

obtaining payments for the products (21 

U.S.C. 830(e)(1)(A)(vii)). The regulated 

seller must certify to DEA that the 

employees have been trained (21 U.S.C. 

830(e)(1)(B)). These regulated sellers 

must also check identifications of 

purchasers and maintain specific 

records (the logbook) of each sale of 

scheduled listed chemical products (21 

U.S.C. 830(e)(1)(A)). The only sales 

exempt from recordkeeping are sales of 

single packages where the package 

contains not more than 60 milligrams of 

pseudoephedrine (21 U.S.C. 

830(e)(1)(A)(iii)). 

On September 26, 2006, DEA 

published in the Federal Register an 

Interim Final Rule, ‘‘Retail Sales of 

Scheduled Listed Chemical Products; 

Self-Certification of Regulated Sellers of 

Scheduled Listed Chemical Products’’ 

(71 FR 56008; corrected at 71 FR 60609, 

October 13, 2006). That rule 

incorporated the standards set forth by 

the CMEA, requiring regulated sellers of 

scheduled listed chemical products to 

maintain logbooks regarding their sales 

on and after September 30, 2006. If a 

regulated seller maintains the logbook 

on paper, DEA requires that the book be 

bound, as is currently the case for 

records of sales of Schedule V 

controlled substances that are sold 

without a prescription (21 CFR 

1314.30(a)(2)). The records must be 

readily retrievable and available for 

inspection and copying by DEA or other 

State or local law enforcement agencies 

(21 U.S.C. 830(e)(1)(C)(i), 21 CFR 

1314.30(i)). Logs must be kept for not 

fewer than two years from the date the 

entry was made (21 CFR 1314.30(g)). 

CMEA required the logs include the 

information entered by the purchaser 

(name, address, signature, date and time 

of sale) and the quantity and form of the 

product sold. 


emcdonald on DSK5VPTVN1PROD with RULES
Federal Register / Vol. 76, No. 231 / Thursday, December 1, 2011 / Rules and Regulations 74697 

DEA permitted by regulation that 

where the record was entered 

electronically, the computer system may 

enter the date and time automatically. 

An electronic signature system, such as 

the ones many stores use for credit card 

purchases, could be employed to 

capture the signature for electronic logs 

(21 CFR 1314.30(c)). The information 

that the seller must enter could be 

accomplished through a point-of-sales 

system and bar code reader. 

Changes to § 1314.30 

On October 14, 2008, the President 

signed the MPPA. The Act amended the 

existing language in 21 U.S.C. 

830(e)(1)(A) by revising clauses (iv) 

through (vi). The purpose of this Act 

was to facilitate the creation of 

electronic logbooks. Several options 

were provided for obtaining signatures 

of purchasers and recording transactions 

at the time of the sale. 

Specifically, the requirements now 

state that a regulated seller of scheduled 

listed chemical products may not sell 

such a product unless the purchaser: 

• Presents a government issued 

photographic identification; and 

• Signs the written logbook with his 

or her name, address, time and date of 

the sale, or signs in one of the following 

ways: 

Æ In the case of an electronic logbook, 

the device must capture the signature in 

an electronic format. 

Æ In the case of a bound paper book, 

a printed sticker must be affixed to the 

book at the time of sale adjacent to the 

signature line. The sticker must display 

the product name, quantity, name of 

purchaser, date and address, or a unique 

identification that can be linked to that 

information. 

Æ In the case of a printed document, 

the document must include a clear line 

for the purchaser’s signature and 

include product name, quantity, name 

and address of purchaser, and date and 

time of sale. 

The MPPA expressly permits the 

regulated seller to capture information 

regarding the name of the product and 

the quantity sold through bar code, 

electronic data capture, or similar 

technology. The regulated seller remains 

responsible for determining that the 

name entered corresponds to the 

photographic identification presented 

by the purchaser. The MPPA indicates 

that if the prospective purchaser enters 

the information into the logbook, the 

regulated seller must determine that the 

name entered in the logbook 

corresponds to the name provided on 

the photographic identification and 

must determine that the date and time 

of the sale as entered by the purchaser 

are correct. If the regulated seller enters 

the information into the logbook, the 

prospective purchaser must verify that 

the information is correct. 

In addition, the written or electronic 

logbook must continue to include a 

notice to purchasers that entering false 

statements or misrepresentations in the 

logbook, or supplying false information 

or identification that results in the 

entry of false statements or 

misrepresentations, may subject the 

purchaser to criminal penalties under 

section 1001 of title 18 of the U.S. Code 

(21 U.S.C. 830(e)(1)(A)(v)). The logbook 

must be maintained by the regulated 

seller for not fewer than two years after 

the date on which the entry is made (21 

U.S.C. 830(e)(1)(A)(vi)). 

The changes made by the MPPA and 

implemented in this rulemaking will 

provide greater flexibility for regulated 

sellers of scheduled listed chemical 

products. These persons may now 

choose several alternative ways in 

which to capture and maintain required 

logbook information: A fully written 

logbook, a fully electronic logbook, or a 

logbook where some information is 

captured electronically and the 

prospective purchaser’s signature is 

captured and linked to that information. 

Discussion of Comments 

DEA received one comment on its 

Notice of Proposed Rulemaking. An 

association representing chain drug 

stores commented that the proposed 

rule allowed for flexibility in complying 

with Federal and State logbook 

requirements. The commenter also 

stated that the proposed rule was both 

logical and time-saving. By allowing 

regulated sellers to scan purchaser 

identifications, the proposed rule makes 

it possible for regulated sellers to 

simultaneously check purchaser 

identification and electronically capture 

purchaser information. 

DEA appreciates the support for its 

Notice of Proposed Rulemaking 

regarding the implementation of the 

MPPA, and is finalizing the Proposed 

Rule without change. 

Regulatory Analyses 

Executive Orders 12866 and 13563 

This final rule implementing the 

MPPA has been developed in 

accordance with the principles of 

Executive Orders 12866 and 13563. As 

discussed above, this action 

incorporates statutory provisions into 

existing regulations. This statutory 

change imposes no new costs on 

regulated sellers of the List I chemicals 

ephedrine, pseudoephedrine, and 

phenylpropanolamine. Rather, it 

provides greater flexibility for regulated 

sellers who may choose to capture 

required logbook information in a 

written form, in an electronic form, or 

in a manner that combines written and 

electronic information. While not 

economically significant, this final rule 

has been reviewed by the Office of 

Management and Budget. 

Executive Order 12988 

This regulation meets the applicable 

standards set forth in sections 3(a) and 

3(b)(2) of Executive Order 12988 Civil 

Justice Reform to eliminate ambiguity, 

minimize litigation, establish clear legal 

standards, and reduce burden. 

Executive Order 13132 

This rulemaking does not preempt or 

modify any provision of State law, 

impose enforcement responsibilities on 

any State, or diminish the power of any 

State to enforce its own laws. 

Accordingly, this rulemaking does not 

have federalism implications warranting 

the application of Executive Order 

13132. 

Executive Order 13175 

This rule is required by statute, will 

not have tribal implications and will not 

impose substantial direct compliance 

costs on Indian tribal governments. 

Regulatory Flexibility Act 

This rule has been reviewed in 

accordance with the Regulatory 

Flexibility Act (5 U.S.C. 601–612), and 

the Deputy Assistant Administrator 

certifies that this rule will not have a 

significant economic impact on a 

substantial number of small entities. 

This rule simply incorporates the 

statutory provisions of the MPPA into 

existing regulations. This rule will 

provide greater flexibility to regulated 

sellers, permitting them to capture 

required logbook information in a 

variety of ways. 

Paperwork Reduction Act of 1995 

Although the requirements of the 

MPPA revise the ways in which logbook 

information may be captured or 

presented, these requirements are not 

substantially different than the 

previously existing requirements for 

documentation of sales in logbooks. 

DEA believes that these revised 

requirements will have a negligible 

impact on the time estimated to 

document a sale. Estimates of this time 

burden are included in information 

collection 1117–0046, ‘‘Certification, 

Training, and Logbooks for Regulated 

Sellers of Scheduled Listed Chemical 

Products.’’ Therefore, as DEA does not 

believe that the burden associated with 


emcdonald on DSK5VPTVN1PROD with RULES
74698 Federal Register / Vol. 76, No. 231 / Thursday, December 1, 2011 / Rules and Regulations 

this collection will measurably change, 

DEA is not revising this information 

collection. 

Unfunded Mandates Reform Act of 1995 

This rule will not result in the 

expenditure by State, local, and tribal 

governments, in the aggregate, or by the 

private sector, of $136,000,000 or more 

(adjusted for inflation) in any one year, 

and will not significantly or uniquely 

affect small governments. Therefore, no 

actions were deemed necessary under 

the provisions of the Unfunded 

Mandates Reform Act of 1995. 

Congressional Review Act 

This rule is not a major rule as 

defined by section 804 of the Small 

Business Regulatory Enforcement 

Fairness Act of 1996 (Congressional 

Review Act). This rule will not result in 

an annual effect on the economy of 

$100,000,000 or more, a major increase 

in costs or prices, or have significant 

adverse effects on competition, 

employment, investment, productivity, 

innovation, or on the ability of United 

States-based companies to compete with 

foreign-based companies in domestic 

and export markets. 

List of Subjects in 21 CFR Part 1314 

Drug traffic control, Reporting and 

recordkeeping requirements. 

For the reasons set out above, 21 CFR 

Part 1314 is amended as follows: 

PART 1314—RETAIL SALE OF 

SCHEDULED LISTED CHEMICAL 

PRODUCTS 

■ 1. The authority citation for Part 1314 

continues to read as follows: 

Authority: 21 U.S.C. 802, 830, 842, 871(b), 

875, 877, 886a. 

■ 2. Section 1314.30 is revised to read 

as follows: 

§ 1314.30 Recordkeeping for retail 

transactions. 

(a) Except for purchase by an 

individual of a single sales package 

containing not more than 60 milligrams 

of pseudoephedrine, the regulated seller 

must maintain, in accordance with 

criteria issued by the Administrator, a 

written or electronic list of each 

scheduled listed chemical product sale 

that identifies the products by name, the 

quantity sold, the names and addresses 

of the purchasers, and the dates and 

times of the sales (referred to as the 

‘‘logbook’’). 

(b) The regulated seller must not sell 

a scheduled listed chemical product at 

retail unless the sale is made in 

accordance with the following: 

(1) The purchaser presents an 

identification card that provides a 

photograph and is issued by a State or 

the Federal Government, or a document 

that, with respect to identification, is 

considered acceptable for purposes of 8 

CFR 274a.2(b)(1)(v)(A) and 

274a.2(b)(1)(v)(B). 

(2) The purchaser signs the logbook as 

follows: 

(i) For written logbooks, enters in the 

logbook his name, address, and the date 

and time of the sale. 

(ii) For electronic logbooks, provides 

a signature using one of the following 

means: 

(A) Signing a device presented by the 

seller that captures signatures in an 

electronic format. The device must 

display the warning notice in paragraph 

(d) of this section. Any device used 

must preserve each signature in a 

manner that clearly links that signature 

to the other electronically captured 

logbook information relating to the 

prospective purchaser providing that 

signature. 

(B) Signing a bound paper book. 

(1) The bound paper book must 

include, for such purchaser, either— 

(i) A printed sticker affixed to the 

bound paper book at the time of sale 

that either displays the name of each 

product sold, the quantity sold, the 

name and address of the purchaser, and 

the date and time of the sale, or a unique 

identifier which can be linked to that 

electronic information, or 

(ii) A unique identifier that can be 

linked to that information and that is 

written into the book by the seller at the 

time of sale. 

(2) The purchaser must sign adjacent 

to the printed sticker or written unique 

identifier related to that sale. The bound 

paper book must display the warning 

notice in paragraph (d) of this section. 

(C) Signing a printed document that 

includes, for the purchaser, the name of 

each product sold, the quantity sold, the 

name and address of the purchaser, and 

the date and time of the sale. The 

document must be printed by the seller 

at the time of the sale. The document 

must contain a clearly identified 

signature line for a purchaser to sign. 

The printed document must display the 

warning notice in paragraph (d) of this 

section. Each signed document must be 

inserted into a binder or other secure 

means of document storage immediately 

after the purchaser signs the document. 

(3) The regulated seller must enter in 

the logbook the name of the product and 

the quantity sold. Examples of methods 

of recording the quantity sold include 

the weight of the product per package 

and number of packages of each 

chemical, the cumulative weight of the 

product for each chemical, or quantity 

of product by Universal Product Code. 

These examples do not exclude other 

methods of displaying the quantity sold. 

Such information may be captured 

through electronic means, including 

through electronic data capture through 

bar code reader or similar technology. 

Such electronic records must be 

provided pursuant to paragraph (g) of 

this section in a human readable form 

such that the requirements of paragraph 

(a) of this section are satisfied. 

(c) The logbook maintained by the 

seller must include the prospective 

purchaser’s name, address, and the date 

and time of the sale, as follows: 

(1) If the purchaser enters the 

information, the seller must determine 

that the name entered in the logbook 

corresponds to the name provided on 

the identification and that the date and 

time entered are correct. 

(2) If the seller enters the information, 

the prospective purchaser must verify 

that the information is correct. 

(3) Such information may be captured 

through electronic means, including 

through electronic data capture through 

bar code reader or similar technology. 

(d) The regulated seller must include 

in the written or electronic logbook or 

display by the logbook, the following 

notice: 

WARNING: Section 1001 of Title 18, United 

States Code, states that whoever, with respect 

to the logbook, knowingly and willfully 

falsifies, conceals, or covers up by any trick, 

scheme, or device a material fact, or makes 

any materially false, fictitious, or fraudulent 

statement or representation, or makes or uses 

any false writing or document knowing the 

same to contain any materially false, 

fictitious, or fraudulent statement or entry, 

shall be fined not more than $250,000 if an 

individual or $500,000 if an organization, 

imprisoned not more than five years, or both. 

(e) The regulated seller must maintain 

each entry in the written or electronic 

logbook for not fewer than two years 

after the date on which the entry is 

made. 

(f) A record under this section must 

be kept at the regulated seller’s place of 

business where the transaction 

occurred, except that records may be 

kept at a single, central location of the 

regulated seller if the regulated seller 

has notified the Administration of the 

intention to do so. Written notification 

must be submitted by registered or 

certified mail, return receipt requested, 

to the Special Agent in Charge of the 

DEA Divisional Office for the area in 

which the records are required to be 

kept. 

(g) The records required to be kept 

under this section must be readily 

retrievable and available for inspection 


emcdonald on DSK5VPTVN1PROD with RULES
Federal Register / Vol. 76, No. 231 / Thursday, December 1, 2011 / Rules and Regulations 74699 

and copying by authorized employees of 

the Administration under the provisions 

of section 510 of the Act (21 U.S.C. 880). 

(h) A record developed and 

maintained to comply with a State law 

may be used to meet the requirements 

of this section if the record includes the 

information specified in this section. 

Dated: November 22, 2011. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control. 

[FR Doc. 2011–30630 Filed 11–30–11; 8:45 am] 

BILLING CODE 4410–09–P 

PENSION BENEFIT GUARANTY 

CORPORATION 

29 CFR Part 4044 

Allocation of Assets in SingleEmployer Plans; Valuation of Benefits 

and Assets; Expected Retirement Age 

AGENCY: Pension Benefit Guaranty 

Corporation. 

ACTION: Final rule. 

SUMMARY: This rule amends Pension 

Benefit Guaranty Corporation’s 

regulation on Allocation of Assets in 

Single-Employer Plans by substituting a 

new table for determining expected 

retirement ages for participants in 

pension plans undergoing distress or 

involuntary termination with valuation 

dates falling in 2012. This table is 

needed in order to compute the value of 

early retirement benefits and, thus, the 

total value of benefits under a plan. 

DATES: Effective Date: January 1, 2012. 

FOR FURTHER INFORMATION CONTACT: 

Catherine B. Klion, Manager, Regulatory 

and Policy Division, Legislative and 

Regulatory Department, Pension Benefit 

Guaranty Corporation, 1200 K Street 

NW., Washington, DC 20005, (202) 326– 

4024. (TTY/TDD users may call the 

Federal relay service toll-free at 1–(800) 

877–8339 and ask to be connected to 

(202) 326–4024.) 

SUPPLEMENTARY INFORMATION: The 

Pension Benefit Guaranty Corporation 

(PBGC) administers the pension plan 

termination insurance program under 

Title IV of the Employee Retirement 

Income Security Act of 1974 (ERISA). 

PBGC’s regulation on Allocation of 

Assets in Single-Employer Plans (29 

CFR part 4044) sets forth (in subpart B) 

the methods for valuing plan benefits of 

terminating single-employer plans 

covered under Title IV. Guaranteed 

benefits and benefit liabilities under a 

plan that is undergoing a distress 

termination must be valued in 

accordance with subpart B of part 4044. 

In addition, when PBGC terminates an 

underfunded plan involuntarily 

pursuant to ERISA section 4042(a), it 

uses the subpart B valuation rules to 

determine the amount of the plan’s 

underfunding. 

Under § 4044.51(b) of the asset 

allocation regulation, early retirement 

benefits are valued based on the annuity 

starting date, if a retirement date has 

been selected, or the expected 

retirement age, if the annuity starting 

date is not known on the valuation date. 

Sections 4044.55 through 4044.57 set 

forth rules for determining the expected 

retirement ages for plan participants 

entitled to early retirement benefits. 

Appendix D of part 4044 contains tables 

to be used in determining the expected 

early retirement ages. 

Table I in appendix D (Selection of 

Retirement Rate Category) is used to 

determine whether a participant has a 

low, medium, or high probability of 

retiring early. The determination is 

based on the year a participant would 

reach ‘‘unreduced retirement age’’ (i.e., 

the earlier of the normal retirement age 

or the age at which an unreduced 

benefit is first payable) and the 

participant’s monthly benefit at 

unreduced retirement age. The table 

applies only to plans with valuation 

dates in the current year and is updated 

annually by the PBGC to reflect changes 

in the cost of living, etc. 

Tables II–A, II–B, and II–C (Expected 

Retirement Ages for Individuals in the 

Low, Medium, and High Categories 

respectively) are used to determine the 

expected retirement age after the 

probability of early retirement has been 

determined using Table I. These tables 

establish, by probability category, the 

expected retirement age based on both 

the earliest age a participant could retire 

under the plan and the unreduced 

retirement age. This expected retirement 

age is used to compute the value of the 

early retirement benefit and, thus, the 

total value of benefits under the plan. 

This document amends appendix D to 

replace Table I–11 with Table I–12 in 

order to provide an updated correlation, 

appropriate for calendar year 2012, 

between the amount of a participant’s 

benefit and the probability that the 

participant will elect early retirement. 

Table I–12 will be used to value benefits 

in plans with valuation dates during 

calendar year 2012. 

PBGC has determined that notice of 

and public comment on this rule are 

impracticable and contrary to the public 

interest. Plan administrators need to be 

able to estimate accurately the value of 

plan benefits as early as possible before 

initiating the termination process. For 

that purpose, if a plan has a valuation 

date in 2012, the plan administrator 

needs the updated table being 

promulgated in this rule. Accordingly, 

the public interest is best served by 

issuing this table expeditiously, without 

an opportunity for notice and comment, 

to allow as much time as possible to 

estimate the value of plan benefits with 

the proper table for plans with valuation 

dates in early 2012. 

PBGC has determined that this action 

is not a ‘‘significant regulatory action’’ 

under the criteria set forth in Executive 

Order 12866. 

Because no general notice of proposed 

rulemaking is required for this 

regulation, the Regulatory Flexibility 

Act of 1980 does not apply (5 U.S.C. 

601(2)). 

List of Subjects in 29 CFR Part 4044 

Pension insurance, Pensions. 

In consideration of the foregoing, 29 

CFR part 4044 is amended as follows: 

PART 4044—ALLOCATION OF 

ASSETS IN SINGLE-EMPLOYER 

PLANS 

■ 1. The authority citation for part 4044 

continues to read as follows: 

Authority: 29 U.S.C. 1301(a), 1302(b)(3), 

1341, 1344, 1362. 

■ 2. Appendix D to part 4044 is 

amended by removing Table I–11 and 

adding in its place Table I–12 to read as 

follows: 

Appendix D to Part 4044—Tables Used 

To Determine Expected Retirement Age 


emcdonald on DSK5VPTVN1PROD with RULES